Mineralys Therapeutics, Inc. (MLYS)
29.27
+2.62
(+9.83%)
USD |
NASDAQ |
May 01, 16:00
29.27
0.00 (0.00%)
After-Hours: 16:28
Mineralys Therapeutics EPS Diluted (Quarterly) : -0.4002 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | 2.153 |
| Syndax Pharmaceuticals, Inc. | -0.7786 |
| Regeneron Pharmaceuticals, Inc. | 6.752 |
| Immunic, Inc. | -1.603 |
| Cogent Biosciences, Inc. | -0.6934 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.23M |
| Total Expenses (Quarterly) | 32.23M |
| Enterprise Value | 1.541B |
| Earnings Yield | -8.13% |
| Normalized Earnings Yield | -8.126 |